Loading...
Rationally designed treatment for metastatic colorectal cancer: Current drug development strategies
The therapeutic landscape of metastatic colorectal cancer (mCRC) has changed substantially with the emergence of new molecularly targeted agents (MTA) used as single agents or alongside standard chemotherapy. The use of these MTAs extended the overall survival of patients with mCRC to a level that c...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Baishideng Publishing Group Inc
2014
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4130836/ https://ncbi.nlm.nih.gov/pubmed/25132745 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v20.i30.10288 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|